Loomis Sayles & CO L P Procept Bio Robotics Corp Transaction History
Loomis Sayles & CO L P
- $72.6 Billion
- Q2 2024
A detailed history of Loomis Sayles & CO L P transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,261,608 shares of PRCT stock, worth $121 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,261,608
Previous 1,351,000
6.62%
Holding current value
$121 Million
Previous $66.8 Million
15.43%
% of portfolio
0.11%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding PRCT
# of Institutions
228Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$453 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$335 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$174 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$168 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$131 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.29B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...